Compounds > erythromycin
Page last updated: 2024-08-21

erythromycin and Nasopharyngeal Carcinoma

erythromycin has been researched along with Nasopharyngeal Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nong, L; Qin, S; Tang, Y; Wang, J; Wei, Y; Zhou, Y1
Han, G; Li, B; Wei, Z1

Other Studies

2 other study(ies) available for erythromycin and Nasopharyngeal Carcinoma

ArticleYear
Association of osteopontin polymorphisms with nasopharyngeal carcinoma risk.
    Human immunology, 2014, Volume: 75, Issue:1

    Topics: Adult; Carcinoma; Case-Control Studies; Erythromycin; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Osteopontin; Polymorphism, Genetic

2014
[Treatment of low-dose erythromycin and sinus displacement on sinusitis in patients with nasopharyngeal carcinoma after radiotherapy].
    Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 2011, Volume: 25, Issue:21

    Topics: Adult; Aged; Carcinoma; Combined Modality Therapy; Erythromycin; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Sinusitis

2011